tiprankstipranks
Advertisement
Advertisement

JP:4552 Stock Latest News

JR-446 Trial Signals Early Rare-Disease Catalyst for Medipal and JCR
Company AnnouncementsJR-446 Trial Signals Early Rare-Disease Catalyst for Medipal and JCR
4d ago
JCR Pharmaceuticals Corrects Q1 FY2025 Results While Maintaining Full-Year Profit Outlook
PremiumCompany Announcements
JCR Pharmaceuticals Corrects Q1 FY2025 Results While Maintaining Full-Year Profit Outlook
1M ago
4552
JCR Pharmaceuticals Issues Partial Corrections to FY2024 Consolidated Results Amid Challenging Year
PremiumCompany Announcements
JCR Pharmaceuticals Issues Partial Corrections to FY2024 Consolidated Results Amid Challenging Year
1M ago
4552
JCR Pharmaceuticals Corrects Interim Results but Confirms FY2025 Outlook and Dividend Plan
PremiumCompany Announcements
JCR Pharmaceuticals Corrects Interim Results but Confirms FY2025 Outlook and Dividend Plan
1M ago
4552
JCR Pharmaceuticals Revises Past Financial Results After Accounting Error Review
PremiumCompany Announcements
JCR Pharmaceuticals Revises Past Financial Results After Accounting Error Review
1M ago
4552
JCR Pharmaceuticals Corrects Nine-Month FY2025 Earnings Disclosure
PremiumCompany AnnouncementsJCR Pharmaceuticals Corrects Nine-Month FY2025 Earnings Disclosure
1M ago
4552
JCR Pharmaceuticals Issues Cautious FY2025 Results Briefing Notice
Premium
Company Announcements
JCR Pharmaceuticals Issues Cautious FY2025 Results Briefing Notice
1M ago
4552
JCR Pharmaceuticals Returns to Profit but Warns of Earnings Drop Amid Sales Growth
Premium
Company Announcements
JCR Pharmaceuticals Returns to Profit but Warns of Earnings Drop Amid Sales Growth
1M ago
4552
JCR Pharmaceuticals Raises Earnings Outlook on Firm Sales and FX Gains
PremiumCompany Announcements
JCR Pharmaceuticals Raises Earnings Outlook on Firm Sales and FX Gains
1M ago
4552
JCR Pharmaceuticals Overhauls Leadership and Structure to Drive Global Biopharma Growth
PremiumCompany Announcements
JCR Pharmaceuticals Overhauls Leadership and Structure to Drive Global Biopharma Growth
4M ago
4552
JCR Pharmaceuticals Swings Back to Profit and Lifts Full-Year Outlook
PremiumCompany Announcements
JCR Pharmaceuticals Swings Back to Profit and Lifts Full-Year Outlook
5M ago
4552
JCR Books ¥1.88 Billion Government Subsidy as Extraordinary Income for Q3 FY2025
PremiumCompany Announcements
JCR Books ¥1.88 Billion Government Subsidy as Extraordinary Income for Q3 FY2025
5M ago
4552
JCR Pharmaceuticals Issues FY2025 Q3 Results Briefing With Caution on Outlook
PremiumCompany AnnouncementsJCR Pharmaceuticals Issues FY2025 Q3 Results Briefing With Caution on Outlook
5M ago
4552
JCR Pharmaceuticals Lifts Sales Outlook but Slashes Profit Forecast on Higher R&D and Costs
Premium
Company Announcements
JCR Pharmaceuticals Lifts Sales Outlook but Slashes Profit Forecast on Higher R&D and Costs
5M ago
4552
JCR Pharmaceuticals Briefs Investors on New Agreement with Italfarmaco
Premium
Company Announcements
JCR Pharmaceuticals Briefs Investors on New Agreement with Italfarmaco
5M ago
4552
JCR Pharmaceuticals Strikes Exclusive Japan Deal With Italfarmaco for DMD Drug Givinostat
PremiumCompany Announcements
JCR Pharmaceuticals Strikes Exclusive Japan Deal With Italfarmaco for DMD Drug Givinostat
6M ago
4552
JCR Pharmaceuticals Reports Strong Financial Recovery in First Half of FY2025
PremiumCompany Announcements
JCR Pharmaceuticals Reports Strong Financial Recovery in First Half of FY2025
8M ago
4552
JCR Pharmaceuticals’ JR-141 Study: A Promising Update for Hunter Syndrome Treatment
PremiumCompany Announcements
JCR Pharmaceuticals’ JR-141 Study: A Promising Update for Hunter Syndrome Treatment
8M ago
4552
JCR Pharmaceuticals Advances in MPS IIIB Treatment with JR-446 Study
PremiumCompany Announcements
JCR Pharmaceuticals Advances in MPS IIIB Treatment with JR-446 Study
8M ago
4552
JCR Pharmaceuticals Reports Q1 FY2025 Financial Results with Positive Sales Growth
PremiumCompany AnnouncementsJCR Pharmaceuticals Reports Q1 FY2025 Financial Results with Positive Sales Growth
11M ago
4552
JCR Pharmaceuticals Completes Treasury Stock Disposition for Compensation
Premium
Company Announcements
JCR Pharmaceuticals Completes Treasury Stock Disposition for Compensation
11M ago
4552
JCR Pharmaceuticals Announces Treasury Stock Disposition for Incentive Plan
Premium
Company Announcements
JCR Pharmaceuticals Announces Treasury Stock Disposition for Incentive Plan
12M ago
4552

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >